Gapping up
In reaction to strong earnings/guidance: UEPS +17.9%, VEEV +12.2%, SPLK +6.7%, RALY +6.4%, ANFI +5.4%, AVGO +5.3%, PSUN +4.3%, BONA +3.9%, FRED +2.9%, CO +2.3%, OVTI +2.3%.
M&A news: CRTO +20.7% (may be attributed to Publicis (PUBGY) speculation).
Select Biotech related names showing strength: FOLD +5.2%, AEZS +3.6%, KERX +0.7%, ACHN +0.5%.
Other news: DGLY +7.1% (continue momentum higher), BCRX +4.1% (receives additional NIAID funding to conduct a non-human primate study of BCX4430 in Ebola virus disease), RSH +3.5% (cont strength), CHU +3.4% (agreement with Tesla for charging stations), NXPI +3% (Apple and NXP Semi (NXPI) working on payment system technology for iPhone, according to reports), AZN +2.2% (reports that Pfizer (PFE) and AZN may have resumed merger talks), KNDI +2.1% (China considering new tax on gasoline to help electric car market, according to reports), TSLA +1.7% (has agreed to deal with China Unicom (CHU) for charging stations, according to reports)
Analyst comments: SSYS +1.5% (initiated with a Buy at Stifel), CRH +1.1% (upgraded to Buy from Neutral at Goldman)
In reaction to strong earnings/guidance: UEPS +17.9%, VEEV +12.2%, SPLK +6.7%, RALY +6.4%, ANFI +5.4%, AVGO +5.3%, PSUN +4.3%, BONA +3.9%, FRED +2.9%, CO +2.3%, OVTI +2.3%.
M&A news: CRTO +20.7% (may be attributed to Publicis (PUBGY) speculation).
Select Biotech related names showing strength: FOLD +5.2%, AEZS +3.6%, KERX +0.7%, ACHN +0.5%.
Other news: DGLY +7.1% (continue momentum higher), BCRX +4.1% (receives additional NIAID funding to conduct a non-human primate study of BCX4430 in Ebola virus disease), RSH +3.5% (cont strength), CHU +3.4% (agreement with Tesla for charging stations), NXPI +3% (Apple and NXP Semi (NXPI) working on payment system technology for iPhone, according to reports), AZN +2.2% (reports that Pfizer (PFE) and AZN may have resumed merger talks), KNDI +2.1% (China considering new tax on gasoline to help electric car market, according to reports), TSLA +1.7% (has agreed to deal with China Unicom (CHU) for charging stations, according to reports)
Analyst comments: SSYS +1.5% (initiated with a Buy at Stifel), CRH +1.1% (upgraded to Buy from Neutral at Goldman)